The Center, with Lewwin Pharm as the supporting entity, was established with the approval of the National Engineering Research Center for Modernization of Traditional Chinese Medicine. Its research focuses on preclinical pharmacology and toxicology, pharmacokinetics, and safety evaluation of pediatric traditional Chinese medicine (TCM), TCM and natural drugs, TCM injections and compound formulas, TCM wall-broken decoction pieces, and innovative TCM drugs. The Center aims to enhance the engineering research and development capabilities of the National Engineering Research Center for Modernization of Traditional Chinese Medicine.